Nanologica AB (publ) (STO:NICA)
0.6460
-0.0480 (-6.92%)
Jan 21, 2026, 5:19 PM CET
Nanologica AB Revenue
Nanologica AB had revenue of 2.84M SEK in the quarter ending September 30, 2025, with 365.30% growth. This brings the company's revenue in the last twelve months to 22.65M, up 158.40% year-over-year. In the year 2024, Nanologica AB had annual revenue of 14.54M with 211.17% growth.
Revenue (ttm)
22.65M
Revenue Growth
+158.40%
P/S Ratio
2.71
Revenue / Employee
1.19M
Employees
19
Market Cap
61.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14.54M | 9.87M | 211.17% |
| Dec 31, 2023 | 4.67M | -1.16M | -19.92% |
| Dec 31, 2022 | 5.83M | -8.91M | -60.43% |
| Dec 31, 2021 | 14.75M | -3.59M | -19.58% |
| Dec 31, 2020 | 18.34M | 6.12M | 50.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.67B |
| Elekta AB | 17.57B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Vimian Group AB | 4.65B |
| Vitrolife AB | 3.51B |